This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

6 Home Health Care Stocks to Watch

NEW YORK ( TheStreet) -- Based on the strong industry outlook, latest quarterly results and analysts' hold recommendations, these six home health care stocks have potential upsides ranging from 13% to 60%. On average, these stocks have buy recommendation of 28% and hold rating of 67%, based on a Bloomberg consensus.

These stocks are listed in ascending order of upside potential. Upside is implied by average analysts' price targets.

6. Chemed (CHE - Get Report) operates through two segments: VITAS Group and the Roto-Rooter Group. VITAS focuses on hospice care for terminally ill patients, while Roto-Rooter provides plumbing and drain-cleaning services to both residential and commercial customers.

For the second quarter of 2011, the company reported a 5.8% increase in revenue to $333 million, with the VITAS segment generating a revenue increase of 7.3%. The GAAP diluted earnings per share soared 14.6%, to 94 cents, during the quarter. Net income expanded to $20.3 million from $18.9 million in the second quarter of 2010. Net cash from operating activities doubled to $51.1 million from $20.3 million in the year-ago quarter.

The company recently raised its quarterly dividend to 16 cents per share, up 14.3% from 14 cents paid in the second quarter of 2011. For full year, the company expects revenue growth of 7.5% to 8.5% in VITAS and 6.5% to 8.5% in Roto-Rooter.

EPS, excluding non-cash expense for stock options, non-cash interest expense related to accounting for convertible debt and other items not indicative of ongoing operations, is estimated at $4.7 to $4.8, compared to adjusted earnings per diluted share of $4.17 in 2010.

Of the seven analysts covering the stock, two recommend a buy and three suggest a hold. Data from Bloomberg has analysts forecasting the stock gaining 13.2%, to $65.33, in the upcoming 12 months.

Note: Upside is implied by average analysts price target.
1 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AFAM $42.01 -2.00%
AMED $51.58 -1.10%
CHE $129.77 -1.50%
GTIV $19.19 -1.18%
LHCG $40.39 -1.50%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs